EARLHAM INSTITUTE

Their core work

Earlham Institute is a UK research centre in Norwich specializing in genomics, bioinformatics, and life science data management. They develop and maintain computational infrastructure for biological research, with particular strength in plant genomics and disease resistance mechanisms. Their work spans from building shared European data platforms for life sciences to original research on how cereal crops defend themselves against pathogens. They bridge the gap between large-scale biological data infrastructure and focused molecular biology research.

What they specialise in

How they've shifted over time

Earlham Institute's H2020 trajectory shows a clear shift from infrastructure builder to domain researcher. Their early participation (2015-2019) centred on ELIXIR-EXCELERATE — building shared bioinformatics platforms for health, agriculture, and biotechnology data across Europe. From 2017 onward, they pivoted toward original biological research, coordinating MIREDI on plant immune receptor diversification and later joining EPYC on gut microbiome evolution. The pattern suggests an institute that first established its computational and data management credentials, then applied them to specific biological questions in plant and human health.

Earlham is moving from supporting roles in data infrastructure toward leading original genomics research in plant immunity and microbiome science — expect future projects combining computational biology with crop protection or human gut health.

How they like to work

Earlham Institute operates flexibly — they can lead focused ERC-funded research (MIREDI) and contribute as a specialist partner in large pan-European consortia (ELIXIR-EXCELERATE, EPYC). With 55 unique partners across 18 countries from just 3 projects, they are well-connected relative to their project count, largely thanks to participation in the massive ELIXIR network. This makes them easy to integrate into new consortia — they already have working relationships across much of Europe.

Despite only 3 H2020 projects, Earlham has built a remarkably broad network of 55 partners in 18 countries, primarily through the large ELIXIR-EXCELERATE consortium. Their connections span life science institutes, universities, and data centres across Europe.

What sets them apart

Earlham Institute combines deep bioinformatics and data management capability with hands-on biological research — a rare dual competency. While many institutes either build tools or do biology, Earlham does both, making them valuable partners who can handle data-intensive genomics work end-to-end. Their Norwich location places them near world-class plant science (John Innes Centre, The Sainsbury Laboratory), creating a cluster effect for any plant biology collaboration.

Highlights from their portfolio

• MIREDI
  Their largest project (EUR 883K) and only coordinated effort — an ERC Starting Grant on plant immune receptor diversification, signalling strong independent research capability.
• ELIXIR-EXCELERATE
  Part of the flagship European life science data infrastructure initiative, connecting Earlham to 50+ partners across the continent.
• EPYC
  Most recent project (2021-2026) marks expansion into human gut microbiome research, a significant new direction for the institute.